Editorial: The molecular mechanisms and potential drug targets for remyelination and neuroregeneration

Front Mol Neurosci. 2023 Nov 17:16:1332594. doi: 10.3389/fnmol.2023.1332594. eCollection 2023.

Aleksandra Rutkowska^#^{1

2}, Maria Velasco-Estevez^#³, Sinead A O'Sullivan⁴

¹ Brain Diseases Centre, Medical University of Gdansk, Gdańsk, Poland.
² Department of Anatomy and Neurobiology, Medical University of Gdansk, Gdańsk, Poland.
³ H12O-CNIO Hematological Malignancies Group, Clinical Research Unit, Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain.
⁴ German Centre for Neurodegenerative Diseases, Helmholtz Association of German Research Centers (HZ), Bonn, Germany.

^# Contributed equally.

No abstract available

Keywords: disease-modifying therapies; multiple sclerosis; neurodegeneration; regeneration; remyelination.

Publication types

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.